| DAA593 |
Cancer of colon, rectum and anus |
Pathological |
intestine |
Human |
— |
SeriesMorbidity |
|
| DAA601 |
Cancer of corpus uteri and uterus, part unspecified |
Pathological |
uterus |
Human |
— |
SeriesMorbidity |
|
| DAA591 |
Cancer of esophagus |
Pathological |
oesophagus |
Human |
— |
SeriesMorbidity |
|
| DAA604 |
Cancer of kidney and renal pelvis |
Pathological |
urinary system |
Human |
— |
SeriesMorbidity |
|
| DAA596 |
Cancer of larynx |
Pathological |
larynx |
Human |
— |
SeriesMorbidity |
|
| DAA590 |
Cancer of lip, oral cavity, and pharynx |
Pathological |
tongue |
Human |
— |
SeriesMorbidity |
|
| DAA594 |
Cancer of liver and intrahepatic bile ducts |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|
| DAA607 |
Cancer of lymphoid, hematopoietic and related tissue |
Pathological |
lymphoreticular system |
Human |
— |
SeriesMorbidity |
|
| DAA606 |
Cancer of meninges, brain and other parts of central nervous system |
Pathological |
central nervous system |
Human |
— |
SeriesMorbidity |
|
| DAA597 |
Cancer of trachea, bronchus and lung |
Pathological |
respiratory system |
Human |
— |
SeriesMorbidity |
|
| DAA1679 |
candidate tumor suppressor in ovarian cancer 2 |
Molecular |
lung |
Mouse |
Ovca2 |
4.0% Increase Gene Expression Level |
|
| DAA1683 |
canopy 4 homolog (zebrafish) |
Molecular |
lung |
Mouse |
Cnpy4 |
5.0% Decrease Gene Expression Level |
|
| DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA808 |
Capacity of neuromusclar junctions to transmit impulses decreases |
Physiological |
respiratory system |
Human |
— |
— |
|
| DAA44 |
carbamoyl-phosphate synthetase 1, mitochondrial |
Molecular |
brain |
Human |
CPS1 |
20.0% Increase Gene Expression Level |
|
| DAA908 |
Carbohydrate homeostasis deficits following glucose challenge |
Physiological |
endocrine system |
Human |
— |
— |
|
| DAA1664 |
carbohydrate sulfotransferase 2 |
Molecular |
lung |
Mouse |
Chst2 |
10.0% Decrease Gene Expression Level |
|
| DAA1607 |
carbonic anhydrase 2 |
Molecular |
lung |
Mouse |
Car2 |
5.0% Decrease Gene Expression Level |
|
| DAA443 |
carbonic anhydrase IV |
Molecular |
skeletal muscle |
Human |
CA4 |
6.0% Decrease Gene Expression Level |
|
| DAA31 |
carbonic anhydrase XI |
Molecular |
brain |
Human |
CA11 |
6.0% Decrease Gene Expression Level |
|
| DAA713 |
Cardiac index decreased |
Physiological |
heart |
Human |
— |
— |
|
| DAA1752 |
cardiotrophin 1 |
Molecular |
muscle |
Mouse |
Ctf1 |
4.0% Increase Gene Expression Level |
|
| DAA666 |
Cartilage asbestos transformation |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA664 |
Cartilage calcification interferes with normal diffusion metabolism |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA658 |
Cartilage color changes |
Physiological |
cartilage |
Human |
— |
— |
|